Alastair Kilgour - Profile and Investment Details

Investor Profile

Alastair Kilgour is a Venture Capital, Private Equity Firm, Investor based in London, England, United Kingdom with a diverse investment portfolio that includes companies such as Nu Quantum, 1715Labs, Queen Mary Innovation Board, Legislate Technologies, Brainomix, AQDOT Limited, Porotech, YASA, Opsydia, Proxisense, Istesso, AudioTelligence, Quantum Motion Technologies, Duel, Bramble Energy, Entia, Nyobolt, DIOSynVax, Salunda, Cytoseek, Nozzle.ai, Ceryx MedicalOxford Flow, Mind Foundry, MediaGamma, Silicon MicroGravity, Lumenisity, PolyProx, Oxford Endovascular, Arkivum, PhoreMost, Zentraxa, Symetrica, GeoSpock Ltd., Oxbotica, GaitQ, Mirriad, PredictImmune, Definigen, Undo, Kvasir Analytics, Ilika, GeoSpock, RoboK, Ikarovec, Qkine, NoBACZ, First Light Fusion, Cambridge GaN Devices, Inkpath, Psyomics, Echopoint Medical, Inflowmatix, Cytora, Congenica, Fuel3D, Gripable, Perpetuum, Aqdot, PharmEnable, Phasecraft, Cambridge Touch Technologies Ltd., LettUs Grow, Mogrify, Inductosense, Xampla, PervasID, Echion Technologies, PetMedix, MoA Technology Ltd, Riverlane, Flusso, Paragraf, Carbometrics, Cambridge Photon Technology, Fluidic Analytics, Covatic, Sorex Sensors, . Over time, Alastair Kilgour has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Alastair Kilgour is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Drug Discovery, Leisure, Wellness, Computational Biology, Investment Management, Android, AngularJS, Life Science, Engineering, Artificial Intelligence (AI), Information Technology (IT), Bioinformatics, Software, Biotechnology, Recreation, Hardware, UK-based Startups, Travel, Medical, Big Data, Information Technology, B2B, Therapeutics, Media and Entertainment, Quantum Computing, Pharmaceuticals, Oncology may find it worthwhile to explore potential connections with Alastair Kilgour, as their portfolio suggests a familiarity and interest in this area.

Understanding Alastair Kilgour’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.